MAPT and Parkinson disease: Indeed, the NTK markers αSyn, GFAP, NfL, S100, sTREM2, YKL40 as well as p-tau and the combinations p-tau/a-beta and t-tau/a-beta, predicted cognitive decline in PD during follow-up, revealed by correlating the CSF levels with the cognitive measurements.